Skip to main content
. 2020 Jun 8;18:147. doi: 10.1186/s12916-020-01598-7

Table 1.

Characteristics of the 200 studies included in this review

Trial design Superiority 157 (79%)
Non-inferiority 33 (17%)
Equivalence 3 (2%)
Unclear 7 (4%)
Size Median = 145, interquartile range = 82–400
Multicentre Yes 110 (55%)
No 83 (42%)
Unclear 7 (4%)
Funding Public, charity, or public and charity 68 (34%)
Solely industry 38 (19%)
Others (include combinations) 40 (20%)
No stated funding 54 (27%)